← Back to Search

Hip Brace for Femoroacetabular Impingement Syndrome

N/A
Waitlist Available
Led By Mia Hagen, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient scheduled to undergo arthroscopic osteoplasty and labral repair for femoroacetabular impingement syndrome.
Patient age 14-60 on date of surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 week and 6 month after surgery date
Awards & highlights

Study Summary

This triallooks at the effects of post-hip arthroscopy braces on hip pain, pain scores & hip flexor tendonitis.

Who is the study for?
This trial is for individuals aged 14-60 who are scheduled for hip arthroscopy to treat femoroacetabular impingement syndrome and associated labral tears. Participants must be able to attend a follow-up visit in person 6 weeks after surgery and speak English.Check my eligibility
What is being tested?
The study is testing if wearing a postoperative hip brace reduces pain and prevents tendonitis after hip arthroscopy. It's a randomized controlled trial, meaning participants will be randomly assigned to either use the brace or not, to compare outcomes.See study design
What are the potential side effects?
While the side effects of wearing a postoperative hip brace aren't detailed here, potential issues could include discomfort, skin irritation under the brace, or difficulty with mobility due to the brace.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for surgery to fix hip impingement.
Select...
I am between 14 and 60 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 week and 6 month after surgery date
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 week and 6 month after surgery date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
patient numerical pain ranking scale (NPRS)
Secondary outcome measures
HOOS - Hip disability and Osteoarthritis Outcome Score
NPRS - numerical pain ranking scale
Patient received cortisone injection to hip flexor sheath or bursa
+3 more

Trial Design

2Treatment groups
Active Control
Group I: No InterventionActive Control1 Intervention
This group will not be assigned a hip brace after surgery.
Group II: Hip BraceActive Control1 Intervention
This group will be assigned to wear a hip brace post surgery.

Find a Location

Who is running the clinical trial?

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
483 Previous Clinical Trials
1,086,868 Total Patients Enrolled
University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,279 Total Patients Enrolled
Mia Hagen, MD5.01 ReviewsPrincipal Investigator - University of Washington
University of Washington
5Patient Review
I could not be more pleased with the results of my surgeries — both knees. Dr. Hagen is an excellent doctor and surgeon. I would recommend him to anyone without hesitation.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being administered the drug as part of this research?

"Indeed, clinicaltrials.gov lists this investigation as currently enrolling volunteers. The trial was initially posted on the 1st of November 2020 and has seen its last edit occur in October 2022; 72 people are needed at one medical site to complete the study."

Answered by AI

Are there any opportunities for patient enrollment in this clinical investigation?

"Affirmative. The data hosted on clinicaltrials.gov indicates that this medical study, which went live November 1st 2020, is currently recruiting participants. 72 individuals need to be sourced from a single healthcare facility."

Answered by AI

Is it possible for me to enroll in this scientific experiment?

"Applicants must have a diagnosis of femoroacetabular impingement syndrome and be between 14-60 years old to qualify for this research. The total number of patients needed is 72."

Answered by AI

Is this clinical trial open to participants aged 75 or younger?

"According to the trial's enrollment requirements, 14 is the youngest possible age and 60 is the oldest accepted for this research."

Answered by AI
~16 spots leftby Apr 2025